Secukinumab (anti-IL-17A)
Product Specifications
CAS Number
1229022-83-6
Synonyms
AIN457
Target
Interleukins
Applications
Immunology & Inflammation
Additionnal Information
Secukinumab (anti-IL-17A) (AIN457) is a human IgG1κ monoclonal antibody that binds to the protein interleukin (IL) -17A, and is applied for the treatment of psoriasis, ankylosing spondylitis, and psoriatic arthritis. MW=147.9 kDa.
Storage Conditions
Store the undiluted solution at 4°C in the dark to avoid freeze-thaw cycles
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC742226-500 1x 500 µL
FABP2 (Marker of Metastatic Potential in Colorectal Cancer) (CPTC-FABP2-3), CF740 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
359882-01 50 µL
BHLHB2 (Class E Basic Helix-loop-helix Protein 40, bHLHe40, Class B Basic Helix-loop-helix Protein 2, bHLHb2, Differentially expressed in chondrocytes Protein 1, DEC1, Enhancer-of-split and hairy-Related Protein 2, SHARP-2) discontinued
Sign In for Pricing
View Details 359882-02 100 µL
BHLHB2 (Class E Basic Helix-loop-helix Protein 40, bHLHe40, Class B Basic Helix-loop-helix Protein 2, bHLHb2, Differentially expressed in chondrocytes Protein 1, DEC1, Enhancer-of-split and hairy-Related Protein 2, SHARP-2) discontinued
Sign In for Pricing
View Details